Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Oncoimmunology|March 5, 2016
Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumorsMichele Ardolino, David H RauletSeminars in Immunology|March 18, 2014
NK cell self tolerance, responsiveness and missing self recognitionNataliya Shifrin, David H Raulet, Michele ArdolinoPlos Pathogens|November 19, 2013
A role for host activation-induced cytidine deaminase in innate immune defense against KSHVElena Bekerman, Diana Jeon, Michele Ardolino, et al.Blood|January 7, 2009
Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cellsCristina Cerboni, Michele Ardolino, Angela Santoni, et al.Frontiers in Immunology|January 15, 2013
NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responsesAlessandra Zingoni, Michele Ardolino, Angela Santoni, et al.Trends in Molecular Medicine|July 12, 2025
ILC2s in cancer: good, bad, or stay tuned?Sara Asif, Megan Kinzel, Barbara Vanderhyden, et al.Current Opinion in Immunology|December 22, 2015
Immunosurveillance and immunotherapy of tumors by innate immune cellsAlexandre Iannello, Thornton W Thompson, Michele Ardolino, et al.The Journal of Experimental Medicine|September 18, 2013
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cellsAlexandre Iannello, Thornton W Thompson, Michele Ardolino, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2016
Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and ResponsivenessNataliya Tovbis Shifrin, Djem U Kissiov, Michele Ardolino, et al.The Journal of Clinical Investigation|September 4, 2019
Killers 2.0: NK cell therapies at the forefront of cancer controlJonathan J Hodgins, Sarwat T Khan, Maria M Park, et al.Pageof 4